Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke

BACKGROUND: Atrial fibrillation detected after stroke (AFDAS) has a lower risk of ischemic stroke recurrence than known atrial fibrillation (KAF). While the benefit of oral anticoagulants (OAC) for preventing ischemic stroke recurrence in KAF is well established, their role in patients with AFDAS is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jin-Yi, Liu, Peter Pin-Sung, Sposato, Luciano A., Huang, Huei-Kai, Liu, An-Bang, Lai, Edward Chia-Cheng, Lin, Swu-Jane, Hsieh, Cheng-Yang, Loh, Ching-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354040/
https://www.ncbi.nlm.nih.gov/pubmed/35935644
http://dx.doi.org/10.3389/fcvm.2022.929304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354040/
https://www.ncbi.nlm.nih.gov/pubmed/35935644
http://dx.doi.org/10.3389/fcvm.2022.929304

Ejemplares similares